STOCK TITAN

GENFIT (GNFT) files Form 6-K incorporating press release into F-3 and S-8

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

GENFIT S.A. furnished a Form 6-K as a foreign private issuer, mainly to provide a press release dated September 19, 2025 as Exhibit 99.1. The company states that the contents of this report, including the exhibit, are incorporated by reference into its existing Form F-3 and Form S-8 registration statements, so that the information becomes part of those offering documents from the filing date unless later superseded.

Positive

  • None.

Negative

  • None.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

Date of report: September 19, 2025

 

Commission File Number: 001-38844

 

GENFIT S.A.

(Translation of registrant’s name into English)

 

Parc Eurasanté

885, avenue Eugène Avinée

59120 Loos, France

 

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

☒ Form 20-F  ☐ Form 40-F

 

 

 

 

 

INCORPORATION BY REFERENCE

 

 

 

The contents of this report on Form 6-K (including Exhibit 99.1) are hereby incorporated by reference into the registrant’s registration statement on Form F-3 (File No. 333-271312) and registration statement on Form S-8 (File No. 333-271311) and related prospectuses, as such registration statements and prospectuses may be amended from time to time, and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. Information contained on, or that can be accessed through, any website included in Exhibit 99.1 is expressly not incorporated by reference.

 

 

 

 

 

 

 

 

EXHIBIT LIST

 

     

Exhibit

 

Description

   
99.1   Press Release dated September 19, 2025.
   
     
   
     

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

             
        GENFIT S.A.
       
Date: September 19, 2025       By:   /s/ Pascal PRIGENT
            Name: Pascal PRIGENT
            Title: Chief Executive Officer

 

 

FAQ

What is GENFIT (GNFT) reporting in this Form 6-K?

GENFIT is furnishing a Form 6-K as a foreign private issuer to submit a press release dated September 19, 2025 as Exhibit 99.1. The filing is mainly administrative, updating existing U.S. registration statements by reference.

How does this GENFIT (GNFT) Form 6-K affect its Form F-3 registration?

The Form 6-K specifies that its contents, including Exhibit 99.1, are incorporated by reference into GENFIT’s Form F-3 registration statement. This means the information becomes part of that shelf registration and its related prospectus from the filing date.

How does this GENFIT (GNFT) Form 6-K relate to the company’s Form S-8?

GENFIT states that the Form 6-K, including Exhibit 99.1, is incorporated by reference into its Form S-8 registration statement and related prospectus. This keeps the employee benefit plan registration aligned with the latest disclosed information in this report.

What is included as Exhibit 99.1 in GENFIT’s (GNFT) Form 6-K?

Exhibit 99.1 is a press release dated September 19, 2025. While the detailed contents are not reproduced here, the company makes this press release part of its U.S. registration statements by incorporation by reference.

Is website information in GENFIT’s (GNFT) Exhibit 99.1 incorporated by reference?

The company explicitly states that any information contained on, or accessible through, any website included in Exhibit 99.1 is not incorporated by reference. Only the specific report and exhibit text become part of the registration statements.

Who signed GENFIT’s (GNFT) September 19, 2025 Form 6-K?

The Form 6-K was signed on behalf of GENFIT S.A. by Pascal Prigent, the company’s Chief Executive Officer. This signature confirms the company’s authorization of the furnished information under the Securities Exchange Act of 1934.
Genfit S.A.

NASDAQ:GNFT

View GNFT Stock Overview

GNFT Rankings

GNFT Latest News

GNFT Latest SEC Filings

GNFT Stock Data

242.51M
50.00M
Biotechnology
Healthcare
Link
France
Loos